Integra LifeSciences Reports Third Quarter 2026 Financial Results
PRINCETON, N.J., Oct. 21, 2026 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq: IART), a leading global medical technology company, today reported financial results for the third quarter ending September 30, 2026.
Covered in this story
What has happened since
- Integra Lifesciences Holdings Corp is up 4.1% since this was published.
Price move measured from the close nearest publication to the latest quote.
Analyst targets on Integra Lifesciences Holdings Corp
- Wells Fargo: $12.7 → $15 by Oct 2027 · Equal Weight via Investing.com
Published targets verified against independent reporting and tracked to their dates. Not recommendations from Dalsna Finance.
Call it yourself
No member calls on $IART yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on Integra Lifesciences Holdings Corp →Summary aggregated from GlobeNewswire's public RSS feed. The full reporting belongs to GlobeNewswire — please read it on their site.